The fight against MRSA (Multiresidente Germs) poses one of the biggest challenges of the century for healthcare worldwide. The threat to humanity from this was therefore also addressed at the last G10 summit.
Multidrug resistant Gram-negative bacteria (MRGN) have been on the increase in recent years. Among the most important pathogens in the MRGN include enterobacteria, Pseudomonas aeruginosa and Acinetobacter baumannii.
With our products and system, we are able to drastically reduce the burden of these bacteria and viruses on patients and employees (worker protection) and thus reduce public spending on MRSA/MRGN control. Of course, this also applies to the entire public sector such as educational institutions, public transport (bus, train, metro, aircraft) and other public buildings.